MGIM
PLSE icon

M&G Investment Management’s Pulse Biosciences PLSE Stock Holding History

M&G Investment Management’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-65,132
Closed -$1.43K – 675
2021
Q3 		$1.43K Buy
+65,132
New +$1.4M ﹤0.01% 578

Other funds holding PLSE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
GAM
Griffin Asset Management New York $887M AUM 21.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JMPWA
JP Morgan Private Wealth Advisors San Francisco, California $35B AUM 24.26% 1-Year Est. Return

M&G Investment Management's PLSE Position: Q4 2021 in Review

M&G Investment Management sold out of Pulse Biosciences (PLSE) in Q4 2021, closing a stake of 65,132 shares — an estimated $1.43K sold.

M&G Investment Management first reported a position in PLSE in Q3 2021 and held it in 1 quarter. The position peaked at $1.43K in Q3 2021. 48 funds tracked by Wall St. Rank hold PLSE as of Q4 2021.

  • M&G Investment Management reported no remaining Pulse Biosciences position as of Q4 2021 after selling out during the quarter.
  • M&G Investment Management sold 65,132 Pulse Biosciences shares in Q4 2021, an estimated $1.43K.
  • M&G Investment Management first reported a position in Pulse Biosciences in Q3 2021 and held it in 1 quarter.
  • M&G Investment Management's Pulse Biosciences position peaked at $1.43K in Q3 2021.
  • 48 funds tracked by Wall St. Rank held Pulse Biosciences as of Q4 2021.

Based on M&G Investment Management's 13F filing for Q4 2021, filed 18 Jan 2022.